Search
for
Sort by
Research 361–390 of 1000+
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report
- Citrullination at the Inflammatory Skin Barrier
- 1332 Janus kinase inhibitor increases hair growth by increasing beta-catenin activity in outer root sheath cells
- The Good and Bad News About New Drugs for Treating Alopecia Areata
- What is behind the ‘swarm of bees’ in alopecia areata
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Baricitinib-loaded separable microneedle array patch (S-MAP) based on hyaluronic acid for alopecia areata therapy
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- Epidermal γδ T cells, CD8 T cells and macrophages are increased in number in alopecia areata and express BST2 as part of an interferon-driven antiviral gene signature
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review
- The Frontal Fibrosing Alopecia Treatment Dilemma
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- mTOR signaling in hair follicle and hair diseases: recent progress
- 원형탈모증(alopecia areata)의 최신 이해와 치료
- 022 Exploring the potential of the novel IFNγ aptamer TAGX-0003 as a treatment for alopeciaareata in pre-clinical models
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- CXCL12 inhibits hair growth through CXCR4
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management